CollPlant Biotechnologies (CLGN)
(Delayed Data from NSDQ)
$2.88 USD
+0.11 (3.97%)
Updated Aug 7, 2025 03:59 PM ET
After-Market: $2.87 -0.01 (-0.35%) 5:46 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
CollPlant Biotechnologies Ltd. Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
CLGN 2.88 +0.11(3.97%)
Will CLGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CLGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLGN
CollPlant (CLGN), Stratasys Initiate Study for Breast Implants
Ascendis Pharma (ASND) Surges 8.7%: Is This an Indication of Further Gains?
CLGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CLGN
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS | CLGN Stock News
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial ...
CLGN: Shareholder Sales Won't Benefit Company Directly | CLGN Stock News
CollPlant files to sell 1.27M ordinary shares for holders
CollPlant files to sell 1.27M ordinary shares for holders